Restaging of the mediastinum

Current Opinion in Pulmonary Medicine

Volumn 15, Issue 4, 2009, Pages 308-312

  Herth, Felix J F ^a   Ernst, Armin ^a,b   Eberhardt, Ralf ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Bronchoscopy; Endobronchial ultrasound; Esophageal ultrasound; Lung cancer; Mediastinoscopy; Neoadjuvant chemotherapy; Staging

Indexed keywords

ANTINEOPLASTIC AGENT; FLUCYTOSINE DEOXYRIBOSIDE; FLUORODEOXYGLUCOSE F 18;

CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER STAGING; ENDOBRONCHIAL ULTRASONOGRAPHY; ESOPHAGOSCOPY; HUMAN; LUNG NON SMALL CELL CANCER; MEDIASTINOSCOPY; MEDIASTINUM LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; REPEAT PROCEDURE; REVIEW; THORAX RADIOGRAPHY; TRANSBRONCHIAL ASPIRATION; TREATMENT OUTCOME;

ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; HUMANS; LUNG NEOPLASMS; LYMPH NODES; MEDIASTINUM; NEOADJUVANT THERAPY; NEOPLASM STAGING;

EID: 67449105937     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0b013e32832cbee6     Document Type: Review

References (27)

1. Bueno R, Richards WG, Swanson SJ, et al. Nodal stage after induction therapy for stage IIIA lung cancer determines patient survival. Ann Thorac Surg 2000; 70:1826-1831. (Pubitemid 32015269)
2. Betticher DC, Hsu Schmitz SF, Totsch M, et al. Mediastinal lymph node clearance after docetaxel-cisplatin neoadjuvant chemotherapy is prognostic of survival in patients with stage IIIA pN2non-small-cell lung cancer: a multicenter phase II trial. J Clin Oncol 2003; 21:1752-1759.
3. Lorent N, De Leyn P, Lievens Y, et al. Long-term survival of surgically staged IIIA-N2 non-small-cell lung cancer treated with surgical combined modality approach: analysis of a 7-year prospective experience. Ann Oncol 2004; 15:1645-1653. (Pubitemid 39562605)
4. Goldstraw P. Selection of patients for surgery after induction chemotherapy for N2 non-small-cell lung cancer. J Clin Oncol 2006; 24:3317-3318. (Pubitemid 46638880)
5. Robinson LA, Ruckdeschel JC, Wagner H, Stevens CW, American College of Chest Physicians. Treatment of Nonsmall Cell Lung Cancer-Stage IIIA. Chest 2007; 132:243S-265S.
6. Jaklitsch MT, Herndon HE, Decamp MM, et al. Nodal downstaging predicts survival following induction chemotherapy for stage IIIa (N2) non small cell lung cancer in CALBG protocol #8935. J Surg Oncol 2006; 94:599-606.
7. Rami-Porta R. Induction chemotherapy: a surgeon's perspective. J Thoracic Oncol 2006; 1:605-606. (Pubitemid 47163944)
8. Felip E, Stahel RA, Pavlidis N, et al. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of nonsmall-cell lung cancer (NSCLC). Ann Oncol 2005; 16 (Suppl. 1):i28-i29. (Pubitemid 40872978)
9. Detterbeck FC, Jantz MA, Wallace M, et al. Invasive mediastinal staging of lung cancer. Chest 2007; 132:202S-220S.
10. De Leyn P, Lardinois D, Van Schil PE, et al. ESTS guidelines for preoperative lymph node staging for nonsmall cell lung cancer. Eur J Cardiothorac Surg 2007;32:1-8. (Pubitemid 46874948)
11. Albain KS, Rusch VW, Crowley JJ, et al. Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of southwest oncology group phase II study 8805. J Clin Oncol 1995; 13:1880-1892.
12. Dooms C, Vansteenkiste J. Positron emission tomography in nonsmall cell lung cancer. Curr Opin Pulm Med 2007; 13:256-260. (Pubitemid 46847288)
13. Ohtsuka T, Nomori H, Ebihara A, et al. FDG-PET imaging for lymph node staging and pathologic tumor response after neoadjuvant treatment of nonsmall cell lung cancer. Ann Thorac Cardiovasc Surg 2006; 12: 89-94.
14. Ryu JS, Choi NC, Fischman AJ, et al. FDG-PET in staging and restaging nonsmall cell lung cancer after neoadjuvant chemoradiotherapy: correlation with histopathology. Lung Cancer 2002; 35:179-187. (Pubitemid 34136096)
15. De Leyn P, Stroobants S, de Wever W, et al. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIa-N2 non small cell lung cancer: a Leuven Lung Cancer Group Study. J Clin Oncol 2006; 24:3333-3339. (Pubitemid 46638886)
16. Pottgen C, Levegrun S, Theegarten D, et al. Value of 18 F-fluoro-2-deoxy-D-glucose-positron emission tomography/computed tomography in non-small cell lung cancer for prediction of pathologic response and times to relapse after neoadjuvant chemoradiotherapy. Clin Cancer Res 2006; 12:97-106. (Pubitemid 43166182)
17. Cerfolio RJ, Bryant AS, Ojha B. Restaging patients with N2 (stage IIIa) nonsmallcell lung cancer after neoadjuvant chemoradiotherapy: a prospective study. J Thorac Cardiovasc Surg 2006; 131:1229-1235. (Pubitemid 43792421)
18. Silvestri GA, Gould MK, Margolis ML, et al. Noninvasive staging of nonsmall cell lung cancer. Chest 2007; 132:178S-201S.
19. Herth FJ, Eberhardt R, Vilmann P, et al. Real-time endobronchial ultrasound guided transbronchial needle aspiration for sampling mediastinal lymph nodes. Thorax 2006; 61:795-798. (Pubitemid 44369405)
20. Wallace MB, Pascual JM, Raimondo M, et al. Minimally invasive endoscopic staging of suspected lung cancer. JAMA 2008;6: 299:540-546. (Pubitemid 351214251)
21. Kunst PW, Lee P, Paul MA, et al. Restaging of mediastinal nodes with transbronchial needle aspiration after induction of chemoradiation for locally advanced nonsmall cell lung cancer. J Thorac Oncol 2007; 2:912-915. TBNA trial for restaging. (Pubitemid 47511594)
22. Herth FJ, Annema JT, Eberhardt R, et al. Endobronchial ultrasound with transbronchial needle aspiration for restaging the mediastinum in lung cancer. J Clin Oncol 2008; 26:3346-3350. Large EBUS-TBNA trial for restaging.
23. Annema JT, Veseliç M, Versteegh MI, et al. Mediastinal restaging: EUS-FNA offers a new perspective. Lung Cancer 2003; 42:311-318. (Pubitemid 37468544)
24. De Waele M, Hendriks J, Lauwers P, et al. Nodal status at repeat mediastinoscopy determines survival in nonsmall cell lung cancer with mediastinal nodal involvement, treated by induction therapy. Eur J Cardiothorac Surg 2006; 29:240-243. (Pubitemid 43120410)
25. Pauwels M, Van Schil P, De Backer W, et al. Repeat mediastinoscopy in the staging of lung cancer. Eur J Cardiothorac Surg 1998; 14:271-273. (Pubitemid 28417081)
26. Marra A, Hillejan L, Fechner S, Stamatis G. Remediastinoscopy in restaging of lung cancer after induction therapy. J Thorac Cardiovasc Surg 2008; 135:843-849. One of the largest reMES trials.
27. Van Schil P, Stamatis G. Sensitivity of remediastinoscopy: influence of adhesions, multilevel N2 involvement or surgical technique? J Clin Oncol 2006; 24:5338.